輝瑞 PFE 深 滬
已收盤 08-07 16:00:00 美东时间
26.76
+0.560
+2.14%
華盛通- 最 高26.76
- 今 開26.22
- 成交量 4274.24万股
- 最 低 26.0503
- 昨 收 26.20
- 總市值 1525.23亿
- 52周最高 27.885
- 市盈率 靜 19.74
- 換手率 0.75%
- 52周最低 21.86
- 委 比 -33.94%
- 總股本 57.00亿
- 歷史最高 53.78
- 量 比 0.87
- 振 幅 2.71%
- 歷史最低 -3.9073
- 每 手 1
- 風險率 1.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Earnings Scorecard: 95% of healthcare firms deliver EPS wins this week
Major healthcare heavyweights, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), reported their quarterly earnings this week, pushing the healthcare sector into positive territory after five c...
08-08 23:15
Pfizer Advances COVID Pipeline As Analysts Eye Upside
Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap o...
08-08 23:01
Microsoft, Meta, Netflix, TSMC and Pfizer Insider Shake-Up
Insiders have been trading these 5 stocks: (($MSFT)), (($META)), (($NFLX)), (($...
08-08 21:00
Guggenheim Maintains Buy on Pfizer, Lowers Price Target to $31
Guggenheim analyst Vamil Divan maintains Pfizer (NYSE:PFE) with a Buy and lowers the price target from $35 to $31.
08-08 01:02
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
Pfizer Inc ($PFE), Biontech Se Sponsored Adr ($BNTX) announced an update on the...
08-08 00:30
抢项目，一“马”当先！
（来源：无锡日报） 太湖三万六千顷，碧波依旧。马山半岛上，却已是另一番光景。 盛夏时节，沿太湖国家旅游度假区十里明珠堤驱车南下，万马奔腾的活力和马不停蹄的干劲...
08-07 17:50
Roche introduces two new Cyclospora tests amid U.S. outbreak
Swiss pharma giant Roche (RHHBY) on Thursday rolled out two new PCR tests in collaboration with its subsidiary, TIB MOLBIOL, to detect the parasite Cyclospora as the U.S. continues to grapple with an ...
08-06 22:56
辉瑞持续重组：进一步削减25亿美元开支
（来源：欧洲并购与投资） 辉瑞持续重组：进一步削减25亿美元开支 图片来源于网络 辉瑞（Pfizer）宣布在其现有的重组计划中再追加 25 亿美元的...
08-06 14:58
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Corbus Pharmaceuticals reported progress in its oncology and obesity pipeline, obtaining FDA clearance for the registrational study of CRB-701 in oropharyngeal cancer and completing the last patient visit in the CANYON-1 trial of CRB-913 for obesity. The company also appointed new leadership to strengthen its team. Financially, Corbus reported a net loss of $35 million for the second quarter, with $117.9 million in cash on hand.
08-06 12:00
公司簡介
公司名稱
|
辉瑞
|
行業分類
|
制药
|
業務描述
|
在辉瑞，我们致力于运用科学以及我们的全球资源来改善每个生命阶段的健康状况。在药品的探索、开发和生产过程中，我们多样化的全球保健产品包括生物药品、小分子药品和疫苗，以及许多世界驰名的健康药物。每天，世界各地的辉瑞员工致力于推进健康，以及能够应对我们这个时代最为棘手的疾病的预防和治疗方案。辉瑞还与世界各地的医疗卫生专业人士、政府和社区合作，支持世界各地的人们能够获得更为可靠和可承付的医疗卫生服务。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来，辉瑞一直努力为人们提供更好、更优质的服务。
2016年收入528亿美元，全球63个生产基地，业务遍布全球约175个国家和地区，有9种产品的销售额超过10亿美元，2016年新增140多个研发合作机构，全球96,500余名员工。
|
Earnings Scorecard: 95% of healthcare firms deliver EPS wins this week
Major healthcare heavyweights, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), reported their quarterly earnings this week, pushing the healthcare sector into positive territory after five c...
08-08 23:15
Pfizer Advances COVID Pipeline As Analysts Eye Upside
Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap o...
08-08 23:01
Microsoft, Meta, Netflix, TSMC and Pfizer Insider Shake-Up
Insiders have been trading these 5 stocks: (($MSFT)), (($META)), (($NFLX)), (($...
08-08 21:00
Guggenheim Maintains Buy on Pfizer, Lowers Price Target to $31
Guggenheim analyst Vamil Divan maintains Pfizer (NYSE:PFE) with a Buy and lowers the price target from $35 to $31.
08-08 01:02
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
Pfizer Inc ($PFE), Biontech Se Sponsored Adr ($BNTX) announced an update on the...
08-08 00:30
抢项目，一“马”当先！
（来源：无锡日报） 太湖三万六千顷，碧波依旧。马山半岛上，却已是另一番光景。 盛夏时节，沿太湖国家旅游度假区十里明珠堤驱车南下，万马奔腾的活力和马不停蹄的干劲...
08-07 17:50
Roche introduces two new Cyclospora tests amid U.S. outbreak
Swiss pharma giant Roche (RHHBY) on Thursday rolled out two new PCR tests in collaboration with its subsidiary, TIB MOLBIOL, to detect the parasite Cyclospora as the U.S. continues to grapple with an ...
08-06 22:56
辉瑞持续重组：进一步削减25亿美元开支
（来源：欧洲并购与投资） 辉瑞持续重组：进一步削减25亿美元开支 图片来源于网络 辉瑞（Pfizer）宣布在其现有的重组计划中再追加 25 亿美元的...
08-06 14:58
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Corbus Pharmaceuticals reported progress in its oncology and obesity pipeline, obtaining FDA clearance for the registrational study of CRB-701 in oropharyngeal cancer and completing the last patient visit in the CANYON-1 trial of CRB-913 for obesity. The company also appointed new leadership to strengthen its team. Financially, Corbus reported a net loss of $35 million for the second quarter, with $117.9 million in cash on hand.
08-06 12:00
派息除權日
|
每股總股息
| 派息日期 |
2026-07-24
|
0.43
|
2026-09-01
|
2026-05-08
|
0.43
|
2026-06-12
|
2026-01-23
|
0.43
|
2026-03-06
|
2025-11-07
|
0.43
|
2025-12-01
|
2025-07-25
|
0.43
|
2025-09-02
|
2025-05-09
|
0.43
|
2025-06-13
|
2025-01-24
|
0.43
|
2025-03-07
|
2024-11-08
|
0.42
|
2024-12-02
|
2024-07-26
|
0.42
|
2024-09-03
|
2024-05-09
|
0.42
|
2024-06-14
|
2024-01-25
|
0.42
|
2024-03-01
|
2023-11-09
|
0.41
|
2023-12-04
|
2023-07-27
|
0.41
|
2023-09-05
|
2023-05-11
|
0.41
|
2023-06-09
|
2023-01-26
|
0.41
|
2023-03-03
|
2022-11-03
|
0.40
|
2022-12-05
|
2022-07-28
|
0.40
|
2022-09-06
|
2022-05-12
|
0.40
|
2022-06-10
|
2022-01-27
|
0.40
|
2022-03-04
|
2021-11-04
|
0.39
|
2021-12-06
|
2021-07-29
|
0.39
|
2021-09-07
|
2021-05-06
|
0.39
|
2021-06-04
|
2021-01-28
|
0.39
|
2021-03-05
|
2020-11-05
|
0.38
|
2020-12-01
|
2020-07-30
|
0.38
|
2020-09-01
|
2020-05-07
|
0.38
|
2020-06-05
|
2020-01-30
|
0.38
|
2020-03-06
|
2019-11-07
|
0.36
|
2019-12-02
|
2019-08-01
|
0.36
|
2019-09-03
|
2019-05-09
|
0.36
|
2019-06-07
|
2019-01-31
|
0.36
|
2019-03-01
|
2018-11-08
|
0.34
|
2018-12-03
|
2018-08-02
|
0.34
|
2018-09-04
|
2018-05-10
|
0.34
|
2018-06-01
|
2018-02-01
|
0.34
|
2018-03-01
|
2017-11-09
|
0.32
|
2017-12-01
|
2017-08-02
|
0.32
|
2017-09-01
|
2017-05-10
|
0.32
|
2017-06-01
|
2017-02-01
|
0.32
|
2017-03-01
|
2016-11-08
|
0.30
|
2016-12-01
|
2016-08-03
|
0.30
|
2016-09-01
|
2016-05-11
|
0.30
|
2016-06-01
|
2016-02-03
|
0.30
|
2016-03-02
|
2015-11-04
|
0.28
|
2015-12-01
|
2015-08-05
|
0.28
|
2015-09-02
|
2015-05-06
|
0.28
|
2015-06-02
|
2015-02-04
|
0.28
|
2015-03-03
|
2014-11-05
|
0.26
|
2014-12-02
|
2014-07-30
|
0.26
|
2014-09-03
|
2014-05-07
|
0.26
|
2014-06-03
|
2014-02-05
|
0.26
|
2014-03-04
|
2013-11-06
|
0.24
|
2013-12-03
|
2013-07-31
|
0.24
|
2013-09-04
|
2013-05-08
|
0.24
|
2013-06-04
|
2013-01-30
|
0.24
|
2013-03-05
|
2012-11-07
|
0.22
|
2012-12-04
|
2012-08-01
|
0.22
|
2012-09-05
|
2012-05-09
|
0.22
|
2012-06-05
|
2012-02-01
|
0.22
|
2012-03-06
|
2011-11-08
|
0.20
|
2011-12-06
|
2011-08-03
|
0.20
|
2011-09-06
|
2011-05-11
|
0.20
|
2011-06-07
|
2011-02-02
|
0.20
|
2011-03-01
|
2010-11-04
|
0.18
|
2010-12-01
|
2010-08-04
|
0.18
|
2010-09-01
|
2010-05-05
|
0.18
|
2010-06-01
|
2010-02-03
|
0.18
|
2010-03-02
|
2009-11-04
|
0.16
|
2009-12-01
|
2009-08-05
|
0.16
|
2009-09-02
|
2009-05-06
|
0.16
|
2009-06-02
|
2009-02-04
|
0.32
|
2009-03-03
|
2008-11-05
|
0.32
|
2008-12-02
|
2008-08-06
|
0.32
|
2008-09-03
|
2008-05-07
|
0.32
|
2008-06-03
|
2008-02-06
|
0.32
|
2008-03-04
|
2007-11-07
|
0.29
|
2007-12-04
|
2007-08-08
|
0.29
|
2007-09-05
|
2007-05-09
|
0.29
|
2007-06-05
|
2007-02-07
|
0.29
|
2007-03-06
|
2006-11-08
|
0.24
|
2006-12-05
|
2006-08-09
|
0.24
|
2006-09-05
|
2006-05-10
|
0.24
|
2006-06-06
|
2006-02-08
|
0.24
|
2006-03-07
|
2005-11-08
|
0.19
|
2005-12-06
|
2005-08-10
|
0.19
|
2005-09-06
|
2005-05-11
|
0.19
|
2005-06-07
|
2005-02-09
|
0.19
|
2005-03-08
|
2004-11-09
|
0.17
|
2004-12-03
|
2004-08-11
|
0.17
|
2004-09-03
|
2004-05-12
|
0.17
|
2004-06-04
|
2004-02-11
|
0.17
|
2004-03-05
|
2003-11-12
|
0.15
|
2003-12-04
|
2003-08-13
|
0.15
|
2003-09-04
|
2003-05-14
|
0.15
|
2003-06-05
|
2003-01-15
|
0.15
|
2003-02-14
|
2002-11-13
|
0.13
|
2002-12-05
|
2002-08-14
|
0.13
|
2002-09-05
|
2002-05-15
|
0.13
|
2002-06-06
|
2002-02-13
|
0.13
|
2002-03-07
|
2001-11-14
|
0.11
|
2001-12-06
|
2001-08-15
|
0.11
|
2001-09-06
|
2001-05-16
|
0.11
|
2001-06-07
|
2001-02-14
|
0.11
|
2001-03-08
|
2000-11-15
|
0.09
|
2000-12-07
|
2000-08-16
|
0.09
|
2000-09-07
|
2000-05-09
|
0.09
|
2000-06-08
|
2000-02-16
|
0.09
|
2000-03-09
|
1999-11-09
|
0.08
|
1999-12-09
|
1999-08-04
|
0.08
|
1999-09-09
|
1999-05-05
|
0.22
|
1999-06-10
|
1999-02-10
|
0.22
|
1999-03-11
|
1998-11-04
|
0.19
|
1998-12-10
|
1998-08-05
|
0.19
|
1998-09-10
|
1998-05-06
|
0.19
|
1998-06-11
|
1998-02-04
|
0.19
|
1998-03-12
|
1997-11-05
|
0.17
|
1997-12-11
|
1997-07-30
|
0.17
|
1997-09-11
|
1997-05-07
|
0.34
|
1997-06-12
|
1997-02-05
|
0.34
|
1997-03-13
|
1996-11-06
|
0.30
|
1996-12-12
|
1996-07-31
|
0.30
|
1996-09-12
|
1996-05-08
|
0.30
|
1996-06-13
|
1996-02-07
|
0.30
|
1996-03-14
|
1995-11-08
|
0.26
|
1995-12-21
|
1995-08-02
|
0.26
|
1995-09-21
|
1995-05-08
|
0.52
|
1995-06-15
|
1995-02-06
|
0.52
|
1995-03-16
|
1994-11-04
|
0.47
|
1994-12-15
|
1994-08-01
|
0.47
|
1994-09-15
|
1994-05-09
|
0.47
|
1994-06-16
|
1994-02-07
|
0.47
|
1994-03-17
|
1993-11-05
|
0.42
|
1993-12-16
|
1993-08-02
|
0.42
|
1993-09-16
|
1993-05-10
|
0.42
|
1993-06-17
|
1993-02-08
|
0.42
|
1993-03-18
|
1992-11-16
|
0.37
|
1992-12-17
|
1992-08-03
|
0.37
|
1992-09-17
|
1992-05-11
|
0.37
|
1992-06-18
|
1992-02-03
|
0.37
|
1992-03-19
|
1991-11-08
|
0.33
|
1991-12-19
|
1991-08-01
|
0.33
|
1991-09-19
|
1991-05-13
|
0.33
|
1991-06-20
|
1991-02-22
|
0.66
|
1991-03-21
|
1990-11-09
|
0.60
|
1990-12-20
|
1990-08-06
|
0.60
|
1990-09-20
|
1990-05-14
|
0.60
|
1990-06-21
|
1990-02-05
|
0.60
|
1990-03-22
|
1989-11-13
|
0.55
|
1989-12-21
|
1989-07-24
|
0.55
|
1989-09-21
|
1989-05-15
|
0.55
|
1989-06-21
|
1989-01-23
|
0.55
|
1989-03-22
|
1988-11-15
|
0.50
|
1988-12-20
|
1988-07-25
|
0.50
|
1988-09-20
|
1988-05-16
|
0.50
|
1988-06-20
|
1988-02-12
|
0.50
|
1988-03-21
|
1987-11-16
|
0.45
|
1987-12-21
|
1987-07-27
|
0.45
|
1987-09-21
|
1987-05-14
|
0.45
|
1987-06-19
|
1987-01-26
|
0.45
|
1987-03-20
|
1986-11-17
|
0.41
|
1986-12-19
|
1986-07-28
|
0.41
|
1986-09-19
|
1986-05-14
|
0.41
|
1986-06-20
|
1986-01-27
|
0.41
|
1986-03-21
|
1985-11-15
|
0.37
|
1985-12-20
|
1985-07-26
|
0.37
|
1985-09-20
|
1985-05-20
|
0.37
|
1985-06-21
|
1985-01-28
|
0.37
|
1985-03-21
|
1984-11-13
|
0.33
|
1984-12-20
|
1984-07-26
|
0.33
|
1984-09-20
|
1984-05-14
|
0.33
|
1984-06-21
|
1984-01-26
|
0.33
|
1984-03-21
|
1983-11-14
|
0.29
|
1983-12-21
|
1983-07-26
|
0.29
|
1983-09-21
|
1983-05-13
|
0.58
|
1983-06-21
|
1983-01-26
|
0.58
|
1983-03-21
|
1982-11-15
|
0.46
|
1982-12-21
|
1982-07-27
|
0.46
|
1982-09-21
|
1982-05-13
|
0.46
|
1982-06-21
|
1982-01-26
|
0.46
|
1982-03-19
|
1981-11-13
|
0.40
|
1981-12-21
|
1981-08-13
|
0.40
|
1981-09-21
|
1981-05-13
|
0.40
|
1981-06-19
|
1981-02-11
|
0.40
|
1981-03-20
|
1980-11-28
|
0.36
|
1980-12-22
|
1980-09-02
|
0.36
|
1980-09-29
|
1980-05-29
|
0.36
|
1980-06-27
|
1980-03-03
|
0.36
|
1980-03-30
|
1979-11-22
|
0.33
|
1979-12-18
|
1979-08-27
|
0.33
|
1979-09-20
|
1979-05-23
|
0.33
|
1979-06-21
|
1979-03-05
|
0.33
|
1979-03-29
|
1978-11-21
|
0.30
|
1978-12-17
|
1978-08-28
|
0.30
|
1978-09-21
|
1978-05-25
|
0.30
|
1978-06-22
|
1978-02-27
|
0.27
|
1978-03-23
|
1977-11-24
|
0.27
|
1977-12-18
|
1977-09-01
|
0.24
|
1977-09-22
|
1977-05-30
|
0.24
|
1977-06-23
|
1977-02-28
|
0.24
|
1977-03-24
|
